![]() |
|
|
2 National Public Health Institute, Helsinki FIN 00300, Finland; 3 University of Kuopio, Department of Clinical Nutrition, Kuopio FIN 70211, Finland; and 4 Social Insurance Institution, Helsinki FIN 00100 and Turku FIN 20720, Finland
*To whom correspondence should be addressed. E-mail: jukka.montonen{at}ktl.fi.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Glucose and fructose are natural components of fruits and berries. In addition, a significant proportion of sucrose in sucrose-containing foods, especially beverages, is hydrolyzed into glucose and fructose before the product is consumed. Glucose has a glycemic index of 141 compared with white bread (5) and, accordingly, it has been observed that of sugars, glucose best predicted an increase in blood glucose level (6). Glucose intake predicted an increased risk of type 2 diabetes in a large-scale prospective study in American women (7), but the result was not confirmed in another prospective study (8).
Fructose has been thought to be a safer form of sugar than sucrose due to a lower glycemic response after ingestion. In clinical studies, short-term fructose intake has either improved metabolic control or caused no changes (9,10). However, feeding studies in animals have suggested that fructose intake has a detrimental effect on body weight, plasma glucose, and insulin levels and insulin sensitivity, but the long-term effects of fructose intake in relation to insulin activity and sensitivity in human studies are less clear (11). In a few studies, diets high in fructose have led to reduced insulin sensitivity (12,13) or decreased plasma glucose levels (14,15). Dietary fructose intake was associated with the incidence of type 2 diabetes in a large-scale follow-up study in older women (7), but no significant association was observed in another large-scale cohort of women (8). Cross-sectional analysis based on Nurses' Health Studies I and II showed an association between fructose intake and plasma C-peptide concentration (16). Data on the long-term effects of different sugars on the risk of type 2 diabetes in healthy individuals are sparse and a major need exists for more research in this area, especially on the role of fructose (16). The association between intakes of different sugars and the incidence of type 2 diabetes was studied in a large nationwide cohort of Finns.
| Methods |
|---|
|
|
|---|
Baseline measurements.
All the participants completed a self-administered questionnaire that was checked at the baseline examination. The questionnaire yielded information on previous and current illnesses, medication use, and lifestyle, such as smoking habits and leisure-time physical activity. Subjects were classified according to smoking status as nonsmokers, ex-smokers, smokers of pipes or cigars only, smokers of <15 cigarettes/d, and smokers of
15 cigarettes/d (19). The participants were asked whether or not they engaged in regular leisure-time physical activity.
Body weight and height were measured in light indoor clothing without shoes and the BMI (kg/m2) was calculated. Casual blood pressure was measured using the auscultatory method. Four hypertension categories were formed on the basis of systolic (SBP)5 and diastolic blood pressure (DBP) and antihypertensive medication (19). Persons with SBP
170 mmHg (millimeter of mercury) and DPB
100 mmHg and persons using antihypertensive medication were considered definitely hypertensive. Persons with SBP
160 mmHg and DBP
95 mmHg but not defined as hypertensive were considered to have mild hypertension, and those with SBP <140 mmHg and DBP <90 mmHg were considered normotensive. All persons with intermediate values were considered to have borderline hypertension. The serum cholesterol concentration was determined with an autoanalyzer modification of the Liebermann-Burchard reaction (20).
Known cases of diabetes were identified from information given by the participants and a glucose tolerance test was carried out to diagnose new diabetes at baseline (21,22). All persons with previously known or newly diagnosed diabetes at baseline were excluded from the analyses.
Dietary assessment. Total habitual food consumption during the previous year was estimated using a dietary history interview (18). Trained interviewers used a questionnaire listing over 100 food items and mixed dishes common to the Finnish diet. Consumption of foods was estimated per day, week, month, or year according to the choice of the respondent. Individual consumption of food items was converted to grams per day. The ingredients of mixed foods were broken down into their components using a recipe file and the intakes of separate food items were calculated per day. The contents of different sugars in foods were estimated using Finnish food composition tables (23) completed with analyzed values for carbohydrates of Finnish foods (24,25). To take into account the dietary patterns beyond the individual dietary intakes, 2 dietary patterns, a prudent pattern characterized by consumption of fruit and vegetables and a conservative pattern characterized by consumption of butter, potatoes, and whole milk, were identified (26). Individual glucose and fructose intakes were calculated as free monosaccharides independent of sucrose. Furthermore, their combined intakes were also calculated, because it is impossible to differentiate their potential associations with risk of diabetes due to the high correlation between their intakes (Pearson r = 0.99; P < 0.001).
Short- and long-term reproducibility of the food consumption data has been reported previously (27). The intraclass correlation coefficients for short-term repeatability were 0.55 for total intake of sugars, 0.40 for fructose, 0.38 for glucose, 0.68 for lactose, 0.61 for sucrose, and 0.57 for maltose. The corresponding long-term repeatability coefficients for 47 y were 0.36 for total intake of sugars, 0.28 for both fructose and glucose, 0.55 for lactose, 0.30 for sucrose, and 0.33 for maltose.
Approximately one-half of the sucrose was consumed as a sweetener at the table. The sugar was mainly added to coffee or tea or on top of porridge. The other main sources of sucrose were jams and marmalade, beverages, and fruits and berries, providing nearly 30% of the total sucrose intake. Sweetened berry juice (38%), fruits (23%), and jam and marmalade (12%) represented the major sources of dietary fructose and glucose.
Incident type 2 diabetes. During a 12-y follow-up, a total of 177 incident cases of type 2 diabetes were identified from a nationwide registry of patients receiving drug reimbursement for hypoglycemic agents, which is maintained by the Social Insurance Institution (28). Participants in our study population were linked to this register using the individual social-security code assigned to each Finnish citizen. The medical certificates of all the cases were checked and all met the WHO diagnostic criteria for type 2 diabetes (29).
Statistical analysis.
Nutrient intakes were adjusted for total energy intake by the residual method described by Willet and Stampfer (30). The associations between dietary variables and diabetes risk are presented as relative risks. Relative risks of type 2 diabetes, with 95% [CI] between quartiles of different food items and nutrients, were calculated using Cox's model (31). The data for honey and syrup consumption were divided into consumers (>0 g/d) and nonconsumers, because the number of consumers was low. Potential confounding factors, including age (continuous variable), sex (2 categories), BMI (quintiles), energy intake (continuous variable), smoking status [never, past, current (pipe or cigar, <15 or
15 cigarettes/d)], geographical area (6 categories), physical activity (regular or no), family history of diabetes (2 categories), prudent dietary pattern (continuous variable) score, and conservative pattern score (continuous variable), were adjusted for in the different multivariate models. Furthermore, a model including potential intermediate factors, such as serum cholesterol and blood pressure and other cardiovascular risk factors such as histories of infarction, angina pectoris, and cardiac failure, was also used. The potential modifying effect of intermediate and other selected factors was studied by including interaction terms in the model. Tests for trends through the quartiles of intake were carried out on the basis of a likelihood ratio test, treating all variables in the model as continuous by entering the quartile medians.
| Results |
|---|
|
|
|---|
|
|
The total sugar intake had a modest, nonsignificant (P for trend = 0.10) association with the incidence of type 2 diabetes (Table 3). Of the individual sugars, the intakes of fructose and glucose as well as their combined intake were significantly associated with the incidence of type 2 diabetes, whereas no association was observed for sucrose, lactose, or maltose. The relative risks between the extreme quartiles of intake were 1.87 (95% [CI] = 1.19, 2.93; P for trend = 0.003) for fructose and glucose combined and 1.56 (95% [CI] = 0.99, 2.46; P for trend = 0.10) for the total intake of sugars when adjusted for age, sex, BMI, energy intake, smoking, geographical area, physical activity, family history of diabetes, and dietary patterns. The inclusion of serum cholesterol, blood pressure, and histories of infarction, angina pectoris, and cardiac failure in the model modestly attenuated the associations observed (Table 3).
|
Of the food items contributing to sugar intake, greater intakes of sweetened berry juice and soft drinks were associated with the increased risk of type 2 diabetes; jam and marmalade tended to be associated with an increased risk (P for trend = 0.06), and greater consumption of sugar, used as such, suggested a reduced risk (P for trend = 0.08) (Table 4). The relative risks between the extreme quartiles of the consumption were 1.69 (95% [CI] = 1.17, 2.43; P for trend = 0.001) for sweetened berry juice and 1.67 (95% [CI] = 0.98, 2.87; P for trend = 0.01) for soft drinks when adjusted for age, sex, BMI, energy intake, smoking, geographical area, physical activity, family history of diabetes, and dietary patterns. Further adjustment for cardiovascular risk factors such as serum cholesterol, hypertension, and histories of infarction, angina pectoris, and cardiac failure did not affect the results.
|
| Discussion |
|---|
|
|
|---|
The result of this study is in line with the previous prospective analysis of the data from the Iowa Women's Health Study, in which intakes of glucose and fructose were associated with increased risk of type 2 diabetes (7) and with cross-sectional analysis that showed an association between fructose intake and blood C-peptide level (16). However, no significant association was observed in the prospective analysis of the data from the Women's Health Study (8). A high correlation between glucose and fructose intakes, however, makes it impossible to differentiate their associations with diabetes risk.
Among sugars, glucose has been found to be the best predictor of the insulin response (6). Glucose has high glycemic index compared with white bread (5). The possible effect of glucose on the development of type 2 diabetes is mediated by increased stress to insulin secretion due to high glycemic index. The glycemic index or glycemic load has been associated with diabetes incidence in some large-scale cohort studies (3235) but not in all (7,8). Despite the lower glycemic index (5), fructose intake may be related to increased risk of type 2 diabetes through several biological mechanisms (11). A higher fructose intake may play a role in an increase in body weight due to the positive energy balance, because fructose ingestion does not increase the production of insulin and leptin, which contribute to the long-term regulation of food intake and energy expenditure (3638). Positive energy balance leads to obesity that is associated with a higher concentration of nonesterified fatty acids (39), which may reduce insulin sensitivity (40), increase hepatic glucose production (41,42), and have a deleterious effect on the ß cell function (43). Despite the fact that in short-term studies in humans, fructose ingestion did not have a deleterious effect on glucose metabolism and diabetes (44), a reduction in the insulin-binding activity was observed after intake of a large amount of fructose in a small number of normoglycemic men (12) and a diet containing 15% of energy from fructose resulted in significantly higher insulin and glucose responses than diets without fructose after 5 wk (45). Moreover, the long-term feeding of moderate or high amounts of fructose has impaired glucose metabolism and reduced insulin sensitivity in animal studies (4648).
As a reducing sugar, fructose plays a part in the Maillard reaction with proteins and amino acids to form substituted amino sugars, which undergo further reactions and form advanced glycation end products (AGE) (49). It has been suggested that AGE could be involved in the progression of type 2 diabetes (50) and, in fact, an improvement in insulin sensitivity (51) and reduction in the development of type 2 diabetes (52) have been noted in diabetic animals after AGE have been restricted. Fructose is apparently much more reactive than glucose with respect to glycosylation reactions (53).
Another potential mechanism that may have mediated the effect of glucose or fructose is the low satiety of the liquid foods representing important sugar sources. It has been observed that an excess intake of sugar in liquid form is not compensated by the reduction in food and energy intake and therefore promotes weight gain (5456). Accordingly, consumption of sweetened berry juice and soft drinks was associated with an increased diabetes risk in our data, which is consistent with recent findings on the consumption of sweetened beverages and fruit punches and diabetes incidence (57).
A modest inverse association has been observed between sucrose intake and diabetes risk in previous studies (7,8). However, no significant association was observed between total sucrose intake and diabetes risk in our study, but added sugar (sucrose) used as such suggested an inverse nonsignificant association with the diabetes risk in our data.
The prospective design was a strength of this study and the collected detailed dietary data enabled us to take into account potential dietary confounders. However, the dietary history method used has limitations that may have caused some misclassification of subjects. These tend to diminish the associations observed between exposure and outcome (58). The result of the dietary history interview is always a subjective assessment of the respondent's own dietary habits. A period of 1 y is a lengthy time to recall. Food models were used to diminish errors in recall and open-ended questions enabled respondents to be more specific in their answers. To minimize possible bias, trained nutrition professionals used a structured questionnaire.
In general, the short-term repeatability of the dietary history method was relatively good (27). However, rather poor repeatability for glucose and fructose hinders the interpretation of the results and the possibility of chance findings increases. The poorer long-term consistency can be partly explained by changes in Finnish dietary habits (59). Changes in food consumption during follow-up tend to weaken the associations observed (58). For this reason, follow-up in this study was limited to 12 y. Because results did not change notably after excluding incidents during the first 4 y, we conclude that patients diagnosed and needing hypoglycemic medication shortly after the baseline investigation did not influence our results.
During the 12-y follow-up, information on cases of diagnosed type 2 diabetes derived from a nationwide register of drug reimbursements. Patients treated by nutritional therapy only were not included in this register. The loss of statistical power due to missing the cases undergoing dietary therapy only may have weakened the associations observed. On the other hand, in many cases, it is likely that diabetic patients undergoing dietary therapy only will later proceed to a phase where drug therapy is needed. Thus, it is probable that the cases included in this study represent a group of patients with a more severe disease of relatively long duration.
The relation between fructose and glucose intakes and the incidence of type 2 diabetes may be an effect of these particular monosaccharides or it may be a result of confounding due to other factors related to them. It is also possible that residual confounding remained after inaccurate measurement of physical activity, smoking status, or blood pressure.
In summary, this study demonstrated an increased incidence of type 2 diabetes in persons with higher intake of fructose and glucose, as well as the consumption of sugar-sweetened beverages, but not in persons with higher intake of sucrose. Further research is needed to reveal the mechanism behind the observations of this study and the few other prospective studies that suggest increased type 2 diabetes risk in persons with higher consumption of sugar-sweetened beverages or intakes of fructose or glucose.
| FOOTNOTES |
|---|
5 Abbreviations used: AGE, advanced glycation end product; DBP, diastolic blood pressure; SBP, systolic blood pressure. ![]()
Manuscript received 23 January 2007. Initial review completed 14 February 2007. Revision accepted 1 April 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002;25:14898.
2. Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care. 1992;15:146876.[Abstract]
3. Kim HS, Paik HY, Lee KU, Lee HK, Min HK. Effects of several simple sugars on serum glucose and serum fructose levels in normal and diabetic subjects. Diabetes Res Clin Pract. 1988;4:2817.[Medline]
4. Liu G, Coulston A, Hollenbeck C, Reaven G. The effect of sucrose content in high and low carbohydrate diets on plasma glucose, insulin, and lipid responses in hypertriglyceridemic humans. J Clin Endocrinol Metab. 1984;59:63642.
5. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76:556.
6. Bantle J, Laine D, Castle G, Thomas J, Hoogwerf B, Goetz F. Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med. 1983;309:712.[Abstract]
7. Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:92130.
8. Janket SJ, Manson JE, Sesso H, Buring JE, Liu S. A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care. 2003;26:100815.
9. Gaby AR. Adverse effects of dietary fructose. Altern Med Rev. 2005;10:294306.[Medline]
10. Uusitupa MI. Fructose in the diabetic diet. Am J Clin Nutr. 1994;59 Suppl 3:S7537.
11. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:91122.
12. Beck-Nielsen H, Pedersen O, Lindskov H. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr. 1980;33:2738.
13. Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism. 1980;29:9703.[Medline]
14. Bantle JP, Laine DC, Thomas JW. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA. 1986;256:32416.
15. Osei K, Bossetti B. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism. Diabet Med. 1989;6:50611.[Medline]
16. Wu T, Giovannucci E, Pischon T, Hankinson SE, Ma J, Rifai N, Rimm EB. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr. 2004;80:10439.
17. Aromaa A. Epidemiology and public health impact of high blood pressure in Finland. Helsinki: Social Insurance Institution, AL:17; 1981.
18. Järvinen R. Epidemiological follow-up study on dietary antioxidant vitamins. Results from the Finnish Mobile Clinic Health Examination Survey. Helsinki: Social Insurance Institution, Studies in Social Security and Health 11; 1996.
19. Knekt P. Serum alpha-tocopherol and the risk of cancer. Helsinki: Social Insurance Institution, ML:83; 1988.
20. Huang TC, Chen CP, Wefler V, Raftery A. A stable reagent for the Lieberman-Burchard reaction. Application to rapid serum cholesterol determination. Anal Chem. 1961;33:1405507.
21. Montonen J. Plant foods in the prevention of type 2 diabetes mellitus with emphasis on dietary fiber and antioxidant vitamins. Helsinki: National Public Health institute, A13; 2005.
22. Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P. The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl. 1983;673:1120.[Medline]
23. Rastas M, Seppänen R, Knuts L-R, Karvetti R-L, Varo P. Nutrient composition of foods. Helsinki: Social Insurance Institution; 1989.
24. Varo P, Laine R, Veijalainen K, Pero K, Koivistoinen P. Dietary fibre and available carbohydrates in Finnish cereal products. J Agric Sci Finl. 1984;56:3948.
25. Varo P, Veijalainen K, Espo A, Wetterhoff S, Koivistoinen P. Dietary fibre and carbohydrates in Finnish vegetables and fruits. J Agric Sci Finl. 1984;56:4959.
26. Montonen J, Knekt P, Härkänen T, Järvinen R, Heliövaara M, Aromaa A, Reunanen A. Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol. 2005;161:21927.
27. Järvinen R, Seppänen R, Knekt P. Short-term and long-term reproducibility of dietary history interview data. Int J Epidemiol. 1993;22:5207.
28. Reunanen A, Kangas T, Martikainen J, Klaukka T. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care. 2000;23:126571.
29. WHO. Diabetes mellitus: report of a WHO study group. Geneva: WHO; 1985.
30. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:1727.
31. Cox D. Regression models and life-tables. J R Stat Soc B. 1972;34:187220.
32. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20:54550.[Abstract]
33. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277:4727.
34. Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr. 2004;80:34856.
35. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76:S27480.
36. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093103.[Medline]
37. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab. 2002;87:23914.
38. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998;47:5449.[Abstract]
39. McGarry JD. Disordered metabolism in diabetes: have we underemphasized the fat component? J Cell Biochem. 1994;55 Suppl:2938.[Medline]
40. Virkamäki A, Korsheninnikova E, Seppälä-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Häkkinen A-M, Yki-Järvinen H. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes. 2001;50:233743.
41. Rebrin K, Steil G, Getty L, Bergman R. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 1995;44:103845.[Abstract]
42. Steil G, Rebrin K, Mittelman S, Bergman R. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes. 1998;47:71420.[Abstract]
43. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000;11:3516.[Medline]
44. Gerrits P, Tsalikian E. Diabetes and fructose metabolism. Am J Clin Nutr. 1993;58 Suppl 5:S7969.
45. Hallfrisch J, Ellwood KC, Michaelis OE IV, Reiser S, O'Dorisio TM, Prather ES. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr. 1983;113:181926.
46. Blakely SR, Hallfrisch J, Reiser S, Prather ES. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr. 1981;111:30714.
47. Cohen AM, Teitelbaum A, Rosenman E. Diabetes induced by a high fructose diet. Metabolism. 1977;26:1724.[Medline]
48. Fields M, Lewis CG, Lure MD. Responses of insulin to oral glucose and fructose loads in marginally copper-deficient rats fed starch or fructose. Nutrition. 1996;12:5248.[Medline]
49. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:12946.[Medline]
50. Peppa M, Goldberg T, Cai W, Rayfield E, Vlassara H. Glycotoxins: a missing link in the "relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men". Diabetes Care. 2002;25:18989.
51. Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes. 2002;51:20829.
52. Piercy V, Toseland CD, Turner NC. Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice. Metabolism. 1998;47:147780.[Medline]
53. Bunn HF, Higgins PJ. Reaction of monosaccharides with proteins: possible evolutionary significance. Science. 1981;213:2224.
54. De Castro JM. The effects of the spontaneous ingestion of particular foods or beverages on the meal pattern and overall nutrient intake of humans. Physiol Behav. 1993;53:113344.[Medline]
55. DiMeglio DP, Mattes RD. Liquid versus solid carbohydrate: effects on food intake and body weight. Int J Obes Relat Metab Disord. 2000;24:794800.[Medline]
56. Rolls BJ, Kim S, Fedoroff IC. Effects of drinks sweetened with sucrose or aspartame on hunger, thirst and food intake in men. Physiol Behav. 1990;48:1926.[Medline]
57. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292:92734.
58. Willett W. Nutritional epidemiology. New York: Oxford University Press; 1998
59. Pietinen P, Nissinen A, Vartiainen E, Tuomilehto A, Uusitalo U, Ketola A, Moisio S, Puska P. Dietary changes in the North Karelia Project (19721982). Prev Med. 1988;17:18393.[Medline]
This article has been cited by other articles:
![]() |
S. Krishnan, P. F Coogan, D. A Boggs, L. Rosenberg, and J. R Palmer Consumption of restaurant foods and incidence of type 2 diabetes in African American women Am. J. Clinical Nutrition, February 1, 2010; 91(2): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tappy and K.-A. Le Metabolic Effects of Fructose and the Worldwide Increase in Obesity Physiol Rev, January 1, 2010; 90(1): 23 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, F. B. Hu, E. Yeung, W. Willett, and C. Zhang Prospective Study of Pre-Gravid Sugar-Sweetened Beverage Consumption and the Risk of Gestational Diabetes Mellitus Diabetes Care, December 1, 2009; 32(12): 2236 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawasaki, K. Igarashi, T. Koeda, K. Sugimoto, K. Nakagawa, S. Hayashi, R. Yamaji, H. Inui, T. Fukusato, and T. Yamanouchi Rats Fed Fructose-Enriched Diets Have Characteristics of Nonalcoholic Hepatic Steatosis J. Nutr., November 1, 2009; 139(11): 2067 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Brownell, T. Farley, W. C. Willett, B. M. Popkin, F. J. Chaloupka, J. W. Thompson, and D. S. Ludwig The Public Health and Economic Benefits of Taxing Sugar-Sweetened Beverages N. Engl. J. Med., October 15, 2009; 361(16): 1599 - 1605. [Full Text] [PDF] |
||||
![]() |
G. Livesey Fructose Ingestion: Dose-Dependent Responses in Health Research J. Nutr., June 1, 2009; 139(6): 1246S - 1252S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Teff, J. Grudziak, R. R. Townsend, T. N. Dunn, R. W. Grant, S. H. Adams, N. L. Keim, B. P. Cummings, K. L. Stanhope, and P. J. Havel Endocrine and Metabolic Effects of Consuming Fructose- and Glucose-Sweetened Beverages with Meals in Obese Men and Women: Influence of Insulin Resistance on Plasma Triglyceride Responses J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1562 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nettleton, L. M. Steffen, H. Ni, K. Liu, and D. R. Jacobs Jr. Dietary Patterns and Risk of Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care, September 1, 2008; 31(9): 1777 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Douard and R. P. Ferraris Regulation of the fructose transporter GLUT5 in health and disease Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E227 - E237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Palmer, D. A. Boggs, S. Krishnan, F. B. Hu, M. Singer, and L. Rosenberg Sugar-Sweetened Beverages and Incidence of Type 2 Diabetes Mellitus in African American Women Arch Intern Med, July 28, 2008; 168(14): 1487 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. White Weak Association between Sweeteners or Sweetened Beverages and Diabetes J. Nutr., January 1, 2008; 138(1): 138 - 138. [Full Text] [PDF] |
||||
![]() |
J. Montonen, M. Heliovaara, A. Reunanen, P. Knekt, and R. Jarvinen Reply to Dr. White J. Nutr., January 1, 2008; 138(1): 139 - 139. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||